Skip to content

Breast Ultrasonography and Polycystic Ovary Syndrome

Breast Ultrasonography Findings in Patients Over 30 Years With Polycystic Ovary Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04231786
Enrollment
1
Registered
2020-01-18
Start date
2020-01-14
Completion date
2020-07-14
Last updated
2020-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Diseases, Polycystic Ovary

Keywords

breast diseases, fibrocystic breast, polycystic ovari syndrome, fibroadenoma

Brief summary

The results of the evaluation of breast ultrasonography results of patients with polycystic ovary syndrome diagnosis over 30 years of age will be evaluated. Patients admitted to the outpatient clinic and rotterdam criteria according to laboratory data and polycystic ovary syndrome patients diagnosed by the same radiologist the next day after the end of menstrual breast ultrasonography. The aim of this study is to show the association of polycystic ovary syndrome and fibrocystic breast.

Interventions

PROCEDUREBreast ultrasonography findings

Breast ultrasonography findings in patients over 30 years of age diagnosed with polycystic ovary syndrome.

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Over 30 years * diagnosed with polycystic ovary syndrome according to rotterdam criteria * no previous history of breast disease * female patients

Exclusion criteria

* Under 30 years * polycystic ovary syndrome * patients with a previously known history of breast disease

Design outcomes

Primary

MeasureTime frameDescription
Breast ultrasonography findings1 monthBreast ultrasonography findings in patients over 30 years of age diagnosed with polycystic ovary syndrome. THE PRESENCE OF FIBROCISTIC DISEASE WILL BE EVALUATED FOR FIBROADENOMA OR OTHER BREAST DISEASE. YES OR NO ; WILL BE REGISTERED.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026